Charles Young
8Patents
6h-index
10Co-inventors
52Inventor score
Filing activity: Jul 22, 1993 → Sep 20, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5516639A | Antibodies specific for human prostate glandular kallkrein | Emerging Cross-Sectional Technologies | 33 | Expired |
| US6479263B1 | Method for detection of micrometastatic prostate cancer | Chemistry; Metallurgy | 20 | Expired |
| US7383196B1 | Method for operating active clinical guidelines | Physics | 16 | Expired |
| US6235486A | Method for detection of breast cancer | Chemistry; Metallurgy | 14 | Expired |
| US6680342B2 | Methods and compositions for inhibiting the proliferation of prostate cancer cells | Chemistry; Metallurgy | 11 | Expired |
| US6656969B2 | Methods and compositions for inhibiting the proliferation of prostate cancer cells | Human Necessities | 7 | Expired |
| US6093796A | Recombinant hK2 polypeptide | Chemistry; Metallurgy | 3 | Expired |
| US6013471A | DNA encoding hK2 variant polypeptides | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.